Alexza Pharmaceuticals, Inc.
(Other OTC/NBB : ALXA)

( )
ALXA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.59%42.080.9%$926.18m
JNJJohnson & Johnson
1.51%134.480.6%$813.44m
ABBVAbbVie, Inc.
0.59%98.802.1%$739.09m
MRKMerck & Co., Inc.
0.29%69.050.6%$615.33m
LLYEli Lilly and Company
1.13%105.541.0%$482.15m
BMYBristol-Myers Squibb Company
-0.34%60.901.4%$400.65m
AZNAstraZeneca PLC Sponsored ADR
0.45%38.131.3%$173.57m
NVSNovartis AG Sponsored ADR
1.07%83.070.2%$156.34m
GSKGlaxoSmithKline plc Sponsored ADR
1.02%41.250.2%$131.34m
SNYSanofi Sponsored ADR
1.96%42.060.2%$95.07m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.69%47.440.1%$71.10m
LCILannett Company, Inc.
-1.82%13.5037.9%$7.22m
AKTXAkari Therapeutics Plc Sponsored ADR
2.20%1.861.7%$0.04m
EPIXESSA Pharma Inc
-1.61%3.050.0%$0.02m

Company Profile

Alexza Pharmaceuticals, Inc. is a pharmaceutical company, which is focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni on December 19, 2000 and is headquartered in Mountain View, CA.